Skip to main content

Headlines

Omicron is mutating in giant leaps, challenging vaccine efficacy and complicating treatment. But this fall, broad spectrum bivalent vaccines may help mitigate the seemingly never ending spread of COVID-19.

Faculty

Anna Durbin
Professor
International Health

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.